How can observational trials inform and improve clinical practice?

Diabetes Research and Clinical Practice

Volumn 88, Issue SUPPL. 1, 2010, Pages 1-2

  Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIPHASIC INSULIN; INSULIN ASPART; INSULIN DETEMIR;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; HYPOGLYCEMIA; INTERVENTION STUDY; MEDICAL INFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; RESOURCE ALLOCATION;

EID: 77952769428     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.12.026     Document Type: Review

References (12)

1. Freemantle N, Strack T Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials. J. Clin. Epidemiol. 2009, document 2009.07.013. 10.1016/j.jclinepi.
2. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, STROBE initiative, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann. Intern. Med. 2007, 147:W163-W194.
3. Yang W, Zilov A, Soewondo P, Bech OM, Sekkal F, Home PD Observational studies: going beyond the boundaries of randomized controlled trials. Diabetes Res. Clin. Pract. 2010, (in preparation).
4. Shah S, Yang W, Liwak L, Karawagh AM, Sy RAG The A1chieve study: a 60000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogues in daily clinical practice. Diabetes Res. Clin. Pract. 2010, (in preparation).
5. Arredondo A, Zuniga A Economic consequences of epidemiological changes in diabetes in middle-income countries. Diabetes Care 2004, 27:104-109.
6. Unwin N, Alberti KG Chronic non-communicable diseases. Ann. Trop. Med. Parasitol. 2006, 100:455-464.
7. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007, 370:1929-1938.
8. Roglic G, Unwin N Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Res. Clin. Pract. 2010, 87:15-19.
9. Ringborg A, Cropet C, Jonsson B, Gagliardino JJ, Ramachandran A, Lindgren P Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). Int. J. Clin. Pract. 2009, 63:997-1007.
10. Kirigia JM, Sambo HB, Sambo LG, Barry SP Economic burden of diabetes mellitus in the WHO African region. BMC Int. Health Hum. Rights 2009, 9:6.
11. Silverman SL From randomized controlled trials to observational studies. Am. J. Med. 2009, 122:114-120.
12. Baik S, Chacra AR, Guo X, Siva ZO Conducting type 2 diabetes mellitus cost effectiveness analyses in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?. Diabetes Res. Clin. Pract. 2010, (in preparation).